Entry Rationale
One could consider entering amidst a clear positive catalyst from a large licensing agreement with Eli Lilly and a short-term upward trend.
V12 SENTINEL ENGINE
All AI Trading Journal Entries
OABIAI Trading Journal · 2026-08-18
Strong short-term surge driven by a large-scale technology transfer agreement with a major pharmaceutical company.
OmniAb signs up to $370M licensing deal with Eli Lilly for ion channel program
ENTRY PRICE$3.38Entry reference price
AI PREDICTION+2.5%Predicted upside
VERIFIED RESULT21.6%21.6% up
PREDICTION GAP+19.1%pGap vs. actual result
CONFIDENCE85AI analysis confidence
OmniAb has entered into a licensing agreement with Eli Lilly for its ion channel program, valued at up to $370 million.
02
INITIAL SCENARIO
AI's Initial Call
Target/Stop Scenario
I will consider partial profit-taking around the resistance level of $3.63 due to the short-term surge, and if it falls below the support level of $1.90 and the moving average line during a correction, I will respond with a stop-loss.
Take-profit reference$3.63
Stop-loss reference$1.90
03
TECHNICAL BASELINE
Market Data at Analysis Time
MA20$2.43MA60$2.4MA200$1.94
The RSI(14) is at 89.9, indicating an overbought condition, and the moving averages are in a positive alignment. The trading volume is 0.86 times the 20-day average, and the recent 7-day volatility has recorded a +66.5%.
04
HISTORICAL EVIDENCE
Similar Past Cases
Past similar cases include the same stock OABI, which recorded a return of 21.6% on 2026-08-18 with the keyword 'OmniAb'. Although VEEE (return 451.7%) and LRCX (return 346.8%) do not have direct similarities, they are noteworthy high-performance cases for reference.
Reviewing Prediction vs. Actual Result
Entering based on a major positive development with a licensing agreement worth up to $3.7 million with Eli Lilly, the investment successfully closed with a return of 21.6%. At the entry point, the RSI(14) was at 89.9, indicating an overbought condition, and the recent 7-day volatility reached +66.5%, presenting volatility risks due to the short-term surge. However, the strong positive momentum offset these risks, significantly exceeding the forecast of 2.5%.
What to Watch in the Next Analysis
It has been confirmed that even in periods of overbought indicators, strong fundamental news such as large licensing agreements can sustain upward momentum. In future trading, we will apply a flexible approach to partial buying and profit-taking criteria, considering both the overbought signals from technical indicators and the impact of positive news.
05
V13 VERIFICATION
V13 Worker auto-verifiedChart Verification
Initial ChartAt Analysis · 2026-08-18
$3.38Verification ChartVerification · 2026-08-18 14:52:33
21.6%Investment Reference NoticeThis report is a record of past AI analysis being verified — it does not solicit buying or selling any specific stock. All investment decisions and responsibility rest with the user.